Viewing Study NCT02812693


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-05-18 @ 4:46 PM
Study NCT ID: NCT02812693
Status: WITHDRAWN
Last Update Posted: 2018-04-05
First Post: 2016-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification
Sponsor: Joanne Jeter
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stage IIIA Skin Melanoma View
None Stage IIIB Skin Melanoma View
None Stage IIIC Skin Melanoma View
None Stage IV Skin Melanoma View
Keywords: